Salt Lake City-based Biomerics, a medical device contract manufacturer in the interventional device market, has acquired Dependable Plastics of Fairfield, California. Dependable specializes in advanced thermoforming, liquid cast resin molding and additive manufacturing.
With the acquisition, Biomerics will create a new division, Biomerics Interventional Medical Plastics (IMP) Division. Biomerics’ IMP Division with operations in Fairfield and Salt Lake City as a full-service plastics component supplier to the interventional device market with a focus on robotic-assisted surgery.{mprestriction ids="1,3"}
The acquisition marks Biomerics’ second expansion into California, complementing its Micromachining Center of Excellence in Santa Clara.
“In support of our leading customers, Biomerics is excited to launch our Interventional Medical Plastics Division,” said Travis Sessions, CEO of Biomerics. “This acquisition expands our plastic component capabilities for the interventional robotic surgical market. We are excited to welcome the Dependable Plastics employees to the Biomerics team.”
Biomerics IMP will be led by Brett Poole who will assume responsibilities from Dependable founders Harry Marquez and Emil Eger, who started the company in 1983.
“I look forward to joining Biomerics to lead the Dependable Plastics team,” said Poole, who has been named president of Biomerics’ new division. “I look forward to continuing the 40-year history of excellence and integrating these new capabilities into Biomerics.”
“We are delighted to join forces with the Dependable Plastics team carrying on a legacy of superior service,” said Chris Richardson, Biomerics vice president of sales and marketing. “Biomerics IMP, combined with our other divisions, makes Biomerics the single-source vertically integrated solution for the interventional market. We look forward to continuing our deep relationship with our industry-leading customers.”
“The Biomerics IMP Division was created to integrate Biomerics’ various plastics manufacturing component technologies to enable rapid design, development and manufacture of plastics components for the robotic and interventional markets,” said Sessions. “We look forward to partnering with our customers to make important advances in patient care.”{/mprestriction}
